The funding will help support research into the development of potential new modulator therapies for people with cystic fibrosis with an F508del mutation.
Site Search
Showing 21 - 22 of 22 results
News
|
March 7, 2024
|
2 min read
Funding will support a Phase 2b trial of phage therapy for chronic Pseudomonas aeruginosa lung infections.
News
|
March 18, 2024
|
2 min read